Bamako Declaration (2000)

Bamako Declaration (2000)
Name	Bamako Declaration (2000)
Date	2000
Place	Bamako
Adopted by	Organisation of African Unity member Ministers
Subject	Primary health care financing, Essential medicines, Health systems strengthening

Bamako Declaration (2000) was a declaration adopted in Bamako at a meeting of African health authorities in 2000 that reaffirmed commitments to Primary health care and access to Essential medicines. It built on previous continental initiatives such as the Alma-Ata Declaration and engaged institutions including the World Health Organization, the United Nations system, and regional bodies like the African Union. The Declaration sought to translate global frameworks into African policy by addressing financing, procurement, and regulatory mechanisms within national ministries of health.

Background and context

The Declaration emerged amid debates following the Alma-Ata Declaration and the World Health Organization's renewed focus on Primary health care and Health systems strengthening. Regional dynamics included transitions from the Organisation of African Unity to the African Union and responses to the HIV/AIDS pandemic, the Millennium Development Goals, and pressures from World Bank and International Monetary Fund structural adjustment programmes. Influential events and actors shaping the context comprised conferences in Harare, Abuja Conference discussions on Pharmaceutical manufacturing, and policy reports by UNAIDS, UNICEF, Doctors Without Borders, and the Global Fund to Fight AIDS, Tuberculosis and Malaria.

Adoption and signatories

The Declaration was adopted by health ministers and official delegations from member states of the Organisation of African Unity and later referenced by the African Union at subsequent summits. Participants included representatives from Benin, Burkina Faso, Mali, Senegal, Nigeria, Ghana, Kenya, South Africa, Egypt, and other African capitals. International organizations present or associated with endorsement included the World Health Organization, the United Nations Development Programme, the World Bank, and regional centres such as the West African Health Organization and the East, Central and Southern Africa Health Community.

Key commitments and principles

Signatories pledged to strengthen Primary health care delivery, ensure sustainable financing mechanisms for Essential medicines, and bolster procurement and distribution systems. The Declaration emphasized equity in access akin to principles in the Alma-Ata Declaration and linked to goals of the Millennium Development Goals and later the Sustainable Development Goals. It called for national policy reforms consistent with obligations under agreements that affected trade and intellectual property such as the TRIPS Agreement and coordination with multilaterals like the World Trade Organization and the World Health Assembly. Other commitments included support for national regulatory authorities, partnerships with non-governmental organizations like Médecins Sans Frontières, engagement with civil society networks such as Treatment Action Campaign, and collaboration with donor mechanisms including the Global Fund and GAVI.

Implementation and national actions

Countries translated commitments into actions via measures in Benin and Mali that adjusted procurement, in Senegal that reformed supply chains, and in Rwanda and Uganda that piloted community-based initiatives. National ministries coordinated with national drug regulatory authorities, local branches of the World Health Organization, and regional procurement pools such as the African Medicines Regulatory Harmonization initiative. Implementations included adoption of essential medicines lists mirroring WHO Model List of Essential Medicines, use of revolving drug funds, partnerships with academic institutions like Makerere University and University of Cape Town for training, and collaboration with research bodies such as the London School of Hygiene & Tropical Medicine and Institut Pasteur.

Impact and outcomes

The Declaration influenced expanded adoption of national essential medicines policies, increased visibility for pharmaceutical regulation, and motivated regional initiatives like the African Medicines Agency concept and harmonization efforts at meetings convened by the African Union Commission. It contributed to strengthened links among WHO Regional Office for Africa, national authorities, and civil society actors including OXFAM and International Federation of Red Cross and Red Crescent Societies. Outcomes also intersected with increased donor flows from entities such as the Global Fund and policy shifts in response to litigation and activism involving actors like AmfAR and Human Rights Watch.

Challenges and criticisms

Critics argued implementation was uneven across states due to fiscal constraints tied to policy conditionalities from the World Bank and International Monetary Fund and variable governance in capitals from Harare to Tripoli. Concerns were raised about reliance on user fees and revolving funds where advocated, echoing critiques from Doctors Without Borders and scholars from institutions like Harvard University and Johns Hopkins University. Tensions with international intellectual property regimes, exemplified by disputes involving Novartis and negotiations in Geneva at the World Trade Organization, complicated access to affordable medicines. Evaluation reports from UNAIDS and WHO highlighted data gaps and the need for sustained investment.

Legacy and influence on global health policy

The Declaration's legacy includes feeding into continental policy instruments adopted by the African Union and catalysing initiatives such as the creation of frameworks later advanced at the World Health Assembly and in dialogues at United Nations high-level meetings on health. It informed advocacy by networks like People’s Health Movement and shaped donor strategies by organizations including the Global Fund and GAVI. The interplay with legal and trade arenas influenced subsequent policy responses to crises including the Ebola virus epidemic in West Africa and wider pandemic preparedness debates within forums such as the United Nations General Assembly and the G20.

Category:Health policy